La Queue-en-Brie, France

Thierry Martens

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • La Quene en Brie, FR (2018)
  • La Queue en Brie, FR (2015 - 2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Thierry Martens

Introduction

Thierry Martens is a notable inventor based in La Queue-en-Brie, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic agents. With a total of seven patents to his name, Martens has focused on innovative solutions for treating various diseases.

Latest Patents

Martens' latest patents include highly efficient NRF2 activators-co-releasing molecule hybrids. These inventions are designed for use in the treatment of inflammatory or cardiovascular diseases. The first patent details the synthesis and therapeutic applications of these molecules, which are capable of increasing HO-1 protein expression while simultaneously releasing carbon monoxide. Another significant patent involves derivatives of oxazaphosphorines that are pre-activated. This invention outlines methods for preparing these derivatives, their pharmaceutical compositions, and their therapeutic use, particularly in cancer treatment.

Career Highlights

Throughout his career, Thierry Martens has worked with prestigious institutions such as the Gustave Roussy Institute and the National Center for Scientific Research. His work has been instrumental in advancing research in the pharmaceutical field, particularly in developing innovative treatments.

Collaborations

Martens has collaborated with notable colleagues, including Michael Rivard and Angelo Paci. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Thierry Martens is a prominent inventor whose work has significantly impacted the pharmaceutical industry. His innovative patents and collaborations highlight his dedication to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…